The study investigated the role of the P2RY13 protein in lung adenocarcinoma and found that it is significantly downregulated in the tumors and independently predicts poor prognosis. Using single-cell RNA analysis and multiple computational methods, the researchers discovered that P2RY13 is positively correlated with immune infiltration, particularly with T cell markers. Cells with P2RY13 expression were specifically enriched in dendritic cells, which are important for antigen presentation and immune system activation. P2RY13 positive dendritic cells predominated in normal tissues and showed increased activity in antigen presentation and T cell activation. The results suggest that P2RY13 is an independent prognostic biomarker associated with an immunologically active tumor microenvironment. Specific expression of P2RY13 in dendritic cells increases their ability to activate T cells and promotes an antitumor immune response.